Probable adverse reaction to a pharmaceutical excipient

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 89, Issue 2, 2004, Pages

  Hall, C M ^a   Milligan, D W A ^a   Berrington, J ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; EXCIPIENT; FLUCLOXACILLIN; VANCOMYCIN;

ANAMNESIS; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE REGIMEN; FOLLOW UP; HUMAN; LUNG DISEASE; MALE; NEWBORN; NEWBORN DISEASE; PRIORITY JOURNAL; RESUSCITATION; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME;

EID: 1542407210     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2002.024927     Document Type: Article

References (6)

1. Pharmacia. Summary of product characteristics: Dalacin C phosphate injection. Pharmacia Ltd, UK.
2. Gershanik J, Boecler B, Ensley H, et al. The gasping syndrome and benzyl alcohol poisoning. N Engl J Med 1982;307:1384-8.
3. Hiller JL, Benda GI, Rahatzad M, et al. Benzyl alcohol toxicity: impact on mortality and intraventricular hemorrhage among very low birth weight infants. Pediatrics 1986;77:500-6.
4. American Academy of Pediatrics Committee on Drugs. "Inactive" ingredients in pharmaceutical products: update (subject review). http://www.aap.org/policy/re9706.html.
5. Pawar S, Kumar A. Issues in the formulation of drugs for oral use in children. Pediatr Drugs 2002;4:371-9.
6. Moore TJ, Weiss SR, Kaplan S, et al. Reported adverse drug events in infants and children under 2 years of age. http://www.pediatrics.org/cgi/ content/full/110/5/e53.